# HYDROCODONE BITARTRATE AND ACETAMINOPHEN
> **ANDA207709** · Abbreviated New Drug Application (Generic) · Sponsor: AUROLIFE PHARMA LLC · Approved 2018-09-13
## Drug
- **FDA Application Number:** ANDA207709
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- **Generic name:** HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- **Active ingredients:** ACETAMINOPHEN; HYDROCODONE BITARTRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROLIFE PHARMA LLC
- **Manufacturer:** Aurolife Pharma, LLC
- **First approval:** 2018-09-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207709)
---
*MORVS · CC0 1.0*